SI3081228T1 - Irizin za nego in preprečitev osteoporoze - Google Patents

Irizin za nego in preprečitev osteoporoze

Info

Publication number
SI3081228T1
SI3081228T1 SI201630145T SI201630145T SI3081228T1 SI 3081228 T1 SI3081228 T1 SI 3081228T1 SI 201630145 T SI201630145 T SI 201630145T SI 201630145 T SI201630145 T SI 201630145T SI 3081228 T1 SI3081228 T1 SI 3081228T1
Authority
SI
Slovenia
Prior art keywords
irisin
osteoporosis
care
prevention
Prior art date
Application number
SI201630145T
Other languages
English (en)
Inventor
Maria Grano
Graziana Colaianni
Concetta Cuscito
Giacomina Brunetti
Silvia Colucci
Saverio Cinti
Giorgio Mori
Original Assignee
Universita Degli Studi Di Bari
Universita Politecnica Delle Marche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita Degli Studi Di Bari, Universita Politecnica Delle Marche filed Critical Universita Degli Studi Di Bari
Publication of SI3081228T1 publication Critical patent/SI3081228T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201630145T 2015-04-16 2016-04-14 Irizin za nego in preprečitev osteoporoze SI3081228T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2015A000558A ITMI20150558A1 (it) 2015-04-16 2015-04-16 Irisina per la cura e la prevenzione dell'osteoporosi
EP16165324.1A EP3081228B1 (en) 2015-04-16 2016-04-14 Irisin for care and prevention of osteoporosis

Publications (1)

Publication Number Publication Date
SI3081228T1 true SI3081228T1 (sl) 2019-01-31

Family

ID=53490070

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201630145T SI3081228T1 (sl) 2015-04-16 2016-04-14 Irizin za nego in preprečitev osteoporoze

Country Status (8)

Country Link
US (2) US20170028018A1 (sl)
EP (1) EP3081228B1 (sl)
DK (1) DK3081228T3 (sl)
ES (1) ES2701675T3 (sl)
IT (1) ITMI20150558A1 (sl)
PL (1) PL3081228T3 (sl)
PT (1) PT3081228T (sl)
SI (1) SI3081228T1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3080496A1 (en) * 2017-10-25 2019-05-02 Texas A&M University Uses of irisin
CN111000986A (zh) * 2019-12-10 2020-04-14 上海交通大学医学院附属第九人民医院 鸢尾素在制备防治骨性关节炎药物中的应用
CN112773888A (zh) * 2021-02-04 2021-05-11 上海交通大学医学院附属第九人民医院 鸢尾素在制备防治骨折药物中的应用
WO2023048878A1 (en) * 2021-09-24 2023-03-30 The Trustees Of Indiana University Depletion of fndc5 reduces cancer induced muscle loss/cachexia
CN114588176B (zh) * 2022-02-15 2024-01-23 许静宜 一种研究麦冬皂苷d促进骨质疏松h型血管方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US171355A (en) * 1875-12-21 Improvement in driers
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
GB9912350D0 (en) * 1999-05-26 1999-07-28 European Molecular Biology Lab Embl Modified cytokine
FI117667B (fi) * 2001-07-05 2007-01-15 Univ Zuerich Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
WO2012106615A1 (en) * 2011-02-03 2012-08-09 Xoma Technology Ltd. Methods and materials for enhancing functional protein expression in bacteria
US9047069B2 (en) * 2011-04-12 2015-06-02 Texas Instruments Incorporated Computer implemented method of electing K extreme entries from a list using separate section comparisons
US10093705B2 (en) * 2011-09-13 2018-10-09 Dana-Farber Cancer Institute, Inc. Compositions and methods for brown fat induction and activity using FNDC5

Also Published As

Publication number Publication date
ITMI20150558A1 (it) 2016-10-16
EP3081228A1 (en) 2016-10-19
US20180153960A1 (en) 2018-06-07
ES2701675T3 (es) 2019-02-25
PT3081228T (pt) 2018-12-20
DK3081228T3 (en) 2019-01-14
US20170028018A1 (en) 2017-02-02
US10576127B2 (en) 2020-03-03
EP3081228B1 (en) 2018-09-19
PL3081228T3 (pl) 2019-05-31

Similar Documents

Publication Publication Date Title
IL287437A (en) Flavociclib solid dosage forms
HK1247823A1 (zh) 骨質疏鬆的治療
HK1253049A1 (zh) 糖基相互作用化合物及其使用方法
HK1232137A1 (zh) 治療化合物和組合物
HK1256356A1 (zh) 用於誘導組織形成的化合物及其用途
HUE048503T2 (hu) Dihidropirimidin-2-on vegyületek és gyógyszerészeti alkalmazásai
HK1246689A1 (zh) 溴莫尼定和噻嗎洛爾的固定劑量組合
PL3522921T3 (pl) Zapobieganie alergii
PT3081228T (pt) Irisina para o cuidado e prevenção da osteoporose
HK1256358A1 (zh) 用於誘導組織形成的化合物及其用途
GB201413530D0 (en) Treatment and prevention of malaria
HK1257488A1 (zh) 骨形成
HK1249425A1 (zh) 間-碘苄基胍及其前體的製劑
GB201412010D0 (en) Treatment of hypertransaminasemia
IL286670A (en) Compounds for inducing tissue formation and their uses
HK1256243A1 (zh) 誘導組織形成的化合物及其應用
GB201604865D0 (en) Patient fall prevention
GB201513922D0 (en) Treatment of hyperpigmentation